SCHEMBL5451074

SCHEMBL5451074

COC(=O)c1ccc(COc2ccc3cc(-c4ccc(-c5ccccc5)n4-c4ccccc4)ccc3c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
PKM P14618 1/20 0.53
HPGD P15428 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
PTPN7 P35236 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 5/20 0.47
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.46
PTPN1 P18031 2/20 0.46
CYP3A4 P08684 1/20 0.45
KCNH2 Q12809 1/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
HTT P42858 1/20 0.44
ALOX5 P09917 1/20 0.44
SMPD1 P17405 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5457225 0.89 NR4A2 (0.51) ALDH1A1PKMSMN1; SMN2MAPTNPC1
SCHEMBL5455844 0.81 SLC6A5 (0.46) PTPN7SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL9268448 0.80 NPC1 (0.71) KDM4EALDH1A1HPGDPTPN7SMN1; SMN2
SCHEMBL28152490 0.79 ALOX5 (0.67) HPGDSMN1; SMN2MEN1KMT2AMAPT
SCHEMBL27395439 0.78 RAB9A (0.68) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL4589991 0.78 CYP3A4 (0.53) KDM4EALDH1A1PKMHPGDNPSR1
SCHEMBL5446278 0.78 PTPN7 (0.58) KDM4EALDH1A1NPSR1PTPN7MEN1
SCHEMBL1779167 0.77 ALOX5 (0.59) HPGDSMN1; SMN2MEN1KMT2AMAPT
SCHEMBL27980624 0.77 ALDH1A1 (0.83) KDM4EALDH1A1PKMHPGDNPSR1
SCHEMBL9939319 0.75 PTPN7 (0.56) HPGDNPSR1PTPN7SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070123495-A1 PYRROLO-NAPHTHYL ACIDS AND METHODS FOR USING THEM WYETH (US) 2007-05-31 US disclosed
EP-1781641-A1 PYRROLO-NAPHTHYL ACIDS AS PAI-1 INHIBITORS Wyeth (US) 2007-05-09 EP disclosed
US-7186749-B2 Pyrrolo-naphthyl acids and methods for using them WYETH (US) 2007-03-06 US disclosed
US-20060052349-A1 Pyrrolo-naphthyl acids and methods for using them WYETH (US) 2006-03-09 US disclosed
WO-2006023864-A1 PYRROLO-NAPHTHYL ACIDS AS PAI-1 INHIBITORS WYETH (US) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123495-A1 PYRROLO-NAPHTHYL ACIDS AND METHODS FOR USING THEM SERPINE1, SERPINC1, SERPINB1 KDM4E 4667/4885ALDH1A1 284/4885PKM 1767/4885
US-20060052349-A1 Pyrrolo-naphthyl acids and methods for using them SERPINE1, SERPINC1, SERPINB1 KDM4E 4667/4885ALDH1A1 284/4885PKM 1767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.